TURNING MEDICAL IMAGES INTO LIFE-CHANGING INSIGHTS. With big data analytics and computer vision, Imbio transforms standard medical images into rich visual maps of patient conditions, and quantitative reports that provide physicians detailed data to enable more personalized care decisions. Imbio’s industry-leading suite of pulmonary analysis is fully-automated, delivering analysis results directly to the patient study in just minutes. By combining detailed AI analysis and time-saving automation, Imbio is changing healthcare for millions of patients with chronic lung conditions and the physicians who treat them.
Post-processing of Chest CT scans for COPD analysis. The Imbio LDA analysis performs image segmentation, registration, thresholding, and tissue classification based on standard Chest CT image series. The outputs provided from each analysis are a full DICOM image series with intuitive RGB overlays on the patient scan to highlight abnormalities including areas potentially indicative of emphysema and air trapping helping increase diagnostic confidence. LDA also provides a physician summary report with detailed quantification to support more personalized, data-based diagnosis and care decisions.
Post-processing of Chest CT scans for pulmonary fibrosis and ILD’s. LTA applies advanced computer vision to transform a standard chest CT into a detailed map of the lung textures that are key to identifying ILD’s and other fibrotic conditions (normal, ground glass, reticular, honeycomb and hyperlucent). The outputs provided from each analysis are a full DICOM image series with intuitive texture overlays on the patient scan to highlight abnormalities and increase diagnostic confidence. LTA also provides a physician summary report with detailed quantification of the textures by lung region to enable data-based decisions for drug therapy, clinical procedures and other personalized patient care.